| Fund | Type | Gross assets | Min. |
|---|---|---|---|
| Sofinnova Bioequities Enhanced Master Fund, LP | Hedge | $834.3M | $3M |
| Sofinnova Venture Partners IX, L.P. | Venture Capital | $320.2M | $500K |
| Sofinnova Venture Partners X, L.P. | Venture Capital | $293.9M | $500K |
| Name | Title | Ownership | Since |
|---|---|---|---|
| Alain Louis Azan Control | Shareholder | 5-10% | 1997 |
| Eric Helmut Delbridge Control | General Partner, Public Equity | Under 5% | 2016 |
| Hooman No Middle Name Shahlavi Control | Partner And Chief Legal Officer | 5-10% | 2007 |
Sofinnova Investments, Inc. reports $3.8 billion in regulatory assets under management on its Form ADV.
Sofinnova Investments, Inc. manages 7 private funds with combined gross assets of $1.8 billion.
Sofinnova Investments, Inc. reports 40 employees.
Sofinnova Investments, Inc. is based in Menlo Park, CA and has been SEC-registered since 2017.
Sofinnova Investments, Inc. is not required to publicly disclose fund returns. Form ADV filings include assets, ownership, and service providers, shown above.
| Address | 3000 Sand Hill Road, 3-150, Menlo Park, CA 94025 |
| Phone | 650-681-8420 |
| Fax | 650-322-2037 |
| Office hours | 8:00 a.m. - 5:00 p.m. |
| SEC region | San Francisco Regional Office (SFRO) |
| Discloses disciplinary history | No |
| Discretionary | $3.77B |
| Non-discretionary | $0 |
| Total (RAUM) | $3.77B |